Author: Giorgio Lari (Italy)
Co-authors: Enrico Borrelli, Costanza Barresi, Alessandro Feo, Riccardo Sacconi, Giuseppe Querques, Francesco Bandello
Purpose
The occurrence of retinal thinning after diabetic macular edema (DME) resolution may significantly impact on visual outcomes of patients with diabetic retinopathy. The aim of this study was to assess the relationship of clinical characteristics to the rate of retinal thinning in eyes with DME treated with anti-vascular endothelial growth factor (VEGF) therapy.
Setting/Venue
Retrospective study at San Raffaele Scientific Institute, Milan, Italy.
Methods
In this IRB-approved retrospective analysis, we collected data from subjects with a long-term follow-up (≥3 years) and evidence of resolved DME in at least one visit after the initiation of anti-VEGF therapy (baseline visit). In order to measure the long-term rate of retinal thinning during treatment, a second visit (first visit with evidence of resolved DME after 3 years) was also considered. To assess macular structural changes over time, a longitudinal quantitative topographical assessment of the inner and outer retinal thicknesses was provided. Clinical characteristics were associated with rate of retinal thinning during the follow-up.
Results
We included 57 eyes (51 patients) in the analysis. Mean changes over the study period in inner and outer retinal thicknesses were -8.8±15.2 μm and -5.5±10.5 μm, -10.5±20.0 μm and -3.7±14.6 μm, -4.1±19.9 μm -2.0±14.1 μm in the perifoveal, parafoveal and foveal regions. In multivariate regression analysis, a thinning in perifoveal outer retina (p=0.021), parafoveal inner retina (p=0.041), parafoveal outer retina (p=0.003), foveal inner retina (p=0.002), and foveal outer retina (p=0.004) were associated with frequency of central macular thickness reaching a value superior to 350 μm within the study period. Similarly, a thinning in foveal outer retina (p=0.004) was associated with frequency of neuroretinal detachment within the study period.
Conlusions
Eyes with DME undergoing anti-VEGF therapy are characterized by a progressive inner and outer retinal thinning over a follow-up of 3 years. Frequency of neuroretinal detachment and central macular thickness reaching a value superior to 350 μm have a significant impact on macular thinning.
Financial Disclosure
None
Comments
-